keyword
https://read.qxmd.com/read/38495409/the-role-of-early-cardiac-resynchronization-therapy-implantation-in-dilated-cardiomyopathy-patients-with-narrow-qrs-carrying-lamin-a-c-mutation
#21
JOURNAL ARTICLE
Miry Blich, Wisam Darawsha, Allon Eyal, Faheem Shehadeh, Monther Boulous, Lior Gepstein, Mahmoud Suleiman
BACKGROUND: Dilated cardiomyopathy (DCM) caused by Lamin A/C gene (LMNA) mutation is complicated with atrioventricular conduction disturbances, malignant ventricular arrhythmias and progressive severe heart failure. OBJECTIVE: We hypothesized that early cardiac resynchronization therapy (CRT) implantation in LMNA mutation carriers with an established indication for pacemaker or implantable cardioverter defibrillator (ICD), may preserve ejection fraction, and delay disease progression to end stage heart failure...
2024: American Journal of Cardiovascular Disease
https://read.qxmd.com/read/38493989/device-detected-atrial-sensing-amplitudes-as-a-marker-of-increased-risk-for-new-onset-and-progression-of-atrial-high-rate-episodes
#22
JOURNAL ARTICLE
Mauro Biffi, Eduardo Celentano, Massimo Giammaria, Antonio Curnis, Giovanni Rovaris, Matteo Ziacchi, Gennaro Miracapillo, Davide Saporito, Matteo Baroni, Fabio Quartieri, Massimiliano Marini, Patrizia Pepi, Gaetano Senatore, Fabrizio Caravati, Valeria Calvi, Luca Tomasi, Gerardo Nigro, Luca Bontempi, Francesca Notarangelo, Vincenzo Ezio Santobuono, Giulio Boggian, Giuseppe Arena, Francesco Solimene, Marzia Giaccardi, Giampiero Maglia, Alessandro Paoletti Perini, Mario Volpicelli, Daniele Giacopelli, Alessio Gargaro, Saverio Iacopino
BACKGROUND: Atrial high-rate episodes (AHRE) are frequent in patients with cardiac implantable electronic devices. A decrease in device-detected P-wave amplitude may be an indicator of periods of increased risk of AHRE. OBJECTIVE: To assess the association between P-wave amplitude and AHRE incidence. METHODS: Remote monitoring data from 2,579 patients with no history of atrial fibrillation (23% pacemakers, 77% implantable cardioverter-defibrillators [ICDs] of which 40% providing cardiac resynchronization therapy [CRT]) were used to calculate the mean P-wave amplitude during 1 month after implantation...
March 15, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://read.qxmd.com/read/38482616/nano-delivery-of-silibinin-potentiate-the-induction-of-immunogenic-cell-death-icd-in-melanoma-cells
#23
JOURNAL ARTICLE
Mina Amiri, Sevda Jafari, Afsaneh Lavasanifar, Ommoleila Molavi, Soheila Montazersaheb
BACKGROUND: Induction of immunogenic cell death (ICD) in tumors can enhance antitumor immunity and modulate immunosuppression in the tumor microenvironment (TME). OBJECTIVE: In the current study, we investigated the effect of silibinin, a natural compound with anticancer activity, and its polymer-based nanoformulations on the induction of apoptosis and ICD in cancer cells. METHODS: Free and nanoparticulate silibinin were evaluated for their growth-inhibitory effects using an MTT assay...
March 12, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38475737/modern-physiological-approach-to-inappropriate-icd-shocks-due-to-atrial-fibrillation-with-very-fast-ventricular-response-a-case-report
#24
JOURNAL ARTICLE
Catalin Pestrea, Roxana Enache, Ecaterina Cicala, Radu Vatasescu
BACKGROUND: Fast-conducting atrial fibrillation misinterpreted as ventricular tachycardia is the leading cause for inappropriate shocks in patients with implantable cardiac defibrillators (ICD). These inappropriate shocks are associated with significant morbidity and mortality and cause great discomfort and stress. CASE PRESENTATION: We report the case of a patient with ischemic cardiomyopathy, permanent atrial fibrillation, and a single-chamber DF-1 ICD implanted for the primary prevention of sudden cardiac death, who presented for multiple inappropriate internal shocks due to very fast-conducting atrial fibrillation, which was mislabeled as ventricular fibrillation by the ICD...
March 12, 2024: BMC Geriatrics
https://read.qxmd.com/read/38462714/heart-rate-score-in-remote-monitoring-an-additional-tool-for-predicting-outcomes-in-heart-failure-with-reduced-ejection-fraction
#25
JOURNAL ARTICLE
Maria Inês Barradas, Inês Coutinho Dos Santos, Fabiana Duarte, André Viveiros Monteiro, Anabela Tavares, Dinis Martins
BACKGROUND: Heart rate score (HRS) ≥ 70% has been associated with arrhythmic events and mortality but these studies were not specific for heart failure (HF) patients. We hypothesized that HRS ≥ 70% obtained from remote monitoring (RM) is associated with HF hospitalizations and arrhythmic events in HF with reduced ejection fraction (HFrEF). METHODS: HRS was calculated from RM in patients with HFrEF and ICD or CRT-D. Two groups were defined: HRS ≥ 70% (G1, n = 55) and HRS < 70% (G2, n = 48) RESULTS: A total of 103 patients were included (64...
March 10, 2024: Pacing and Clinical Electrophysiology: PACE
https://read.qxmd.com/read/38452404/combining-cisplatin-with-pinellia-pedatisecta-schott-lipid-soluble-extract-induces-tumor-immunogenic-cell-death-in-cervical-cancer
#26
JOURNAL ARTICLE
Congwen Wang, Mingxing Zhang, Jing Peng, Meng Zhang, Chong Lu, Xingling Qi, Qingyan Luo, Yumeng Wang, Guiling Li
BACKGROUND: Pinellia pedatisecta Schott extract (PE) is extracted from Pinellia pedatisecta Schott (PPS), a traditional Chinese medicinal plant with the potential for direct anticancer effects or eliciting an anti-tumor response by activating the immune system. PURPOSE: To explore PE's ability and mechanism to reconstruct cisplatin's immunogenicity. METHODS: Cervical cancer cells were treated with cisplatin (CDDP) and/or PE. The exposure of calreticulin (CRT) on cell membrane was investigated by flow cytometry...
March 3, 2024: Phytomedicine
https://read.qxmd.com/read/38432972/cardiomyopathy-with-an-lmna-genetic-variant-affecting-three-consecutive-generations-a-case-series
#27
JOURNAL ARTICLE
Naoko Ogawa, Hidekazu Kondo, Yumi Ishii, Kazuki Mitarai, Kumiko Akiyoshi, Hiroko Niwa, Koichi Kato, Minoru Horie, Seiko Ohno, Naohiko Takahashi
We report the case of a family afflicted with cardiac laminopathy who showed atrial fibrillation (AF) and complete atrioventricular block across three generations. Implantable cardioverter defibrillators (ICDs) implantation, or cardiac resynchronization therapy (CRT) were delivered to the three patients (proband; 61 years old, proband's mother: 84 years old, and proband's daughter; 38 years old) to prevent sudden cardiac death or suppress heart failure progression. A novel frameshift mutation (LMNA Exon 9: c...
March 4, 2024: Internal Medicine
https://read.qxmd.com/read/38421401/-history-of-the-implantable-cardioverter-defibrillator-in-germany
#28
REVIEW
Michael Block, Helmut U Klein
The implantable cardioverter-defibrillator (ICD) was a breakthrough in the prevention of sudden cardiac death. After years of technical development in the USA, Michel Mirowski succeeded in proving reliable automatic defibrillation of ventricular tachyarrhythmias through initial human implantations in 1980, despite many obstacles. Nearly 4 years later, the first patients received ICDs at multiple centers in Germany. Subsequently, outside the USA, Germany became the country with highest implantation rates...
February 29, 2024: Herzschrittmachertherapie & Elektrophysiologie
https://read.qxmd.com/read/38412340/stepping-back-for-good-reasons-a-reappraisal-of-the-df-1-connector-for-defibrillator-leads
#29
JOURNAL ARTICLE
Christian Sticherling, Kenneth A Ellenbogen, Haran Burri
The DF-4 defibrillator standard has been rapidly adopted due to its convenience at implantation. There are however tradeoffs compared to the traditional DF-1 standard which are underappreciated. This viewpoint outlines the advantages and limitations of current defibrillator lead standards which should be kept in mind, as they impact the options which are available to deal with issues which may arise.
February 27, 2024: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://read.qxmd.com/read/38386857/heart-rhythm-new-zealand-consensus-statement-on-the-practical-management-of-cardiac-implanted-electronic-devices-in-the-peri-operative-environment
#30
JOURNAL ARTICLE
Emma Guglietta, Sharron Denekamp, Susan Sinclair, Lucy Harris, Paula Bishop, Nivashni Naidoo, Timothy Holliday, Mathew Chacko, Ross Downey, Janice Swanapillai, Andrew Martin, Matthew Webber
Electrosurgery is commonly used during a range of operations in order to maintain effective haemostasis. This can cause electromagnetic interference (EMI) with cardiac implanted electronic devices (CIEDs), which prevents normal device function. CIEDs include pacemakers (PPM), implantable cardiac defibrillators (ICD), cardiac resynchronisation therapy devices-both pacemakers and defibrillators (CRT-P/CRT-D)-and implantable loop recorders (ILRs). Damage to the generator, inhibition of pacing, activation of asynchronous pacing and ventricular fibrillation can all be induced by electrocautery...
February 23, 2024: New Zealand Medical Journal
https://read.qxmd.com/read/38382578/long-term-prognosis-and-prognostic-factors-after-primary-prophylactic-implantable-cardioverter-defibrillator-therapy
#31
JOURNAL ARTICLE
Masafumi Sugawara, Yusuke Kondo, Satoko Ryuzaki, Yutaka Yoshino, Toshinori Chiba, Ryo Ito, Takatsugu Kajiyama, Masahiro Nakano, Yoshio Kobayashi
BACKGROUND: Little is known regarding which patients with ischemic cardiomyopathy (ICM) should be considered for prophylactic therapies, such as an implantable cardioverter-defibrillator (ICD), in the primary percutaneous intervention era. The aim of this study was to investigate the influence of non-sustained ventricular tachycardia (NSVT) on major adverse cardiac events (MACE) in heart failure with reduced ejection fraction (HFrEF) patients. METHODS: We retrospectively analyzed patients of ICM and non-ICM who underwent ICD implantation at our institute from October 2006 to August 2020...
February 19, 2024: Journal of Cardiology
https://read.qxmd.com/read/38373297/ph-responsive-hyaluronic-acid-nanomicelles-for-photodynamic-chemodynamic-synergistic-therapy-trigger-immunogenicity-and-oxygenation
#32
JOURNAL ARTICLE
Hui Zhang, Yujun Bao, Guanghao Li, Siqi Li, Xiong Zhang, Changhong Guo, Xiaodan Wu, Yingxue Jin
Cancer metastasis and invasion are closely related to tumor cell immunosuppression and intracellular hypoxia. Activation of immunogenicity and intracellular oxygenation are effective strategies for cancer treatment. In this study, multifunctional nanomicelle hyaluronic acid and cinnamaldehyde is self-assembled into nanomicelles (HPCNPs) were constructed for immunotherapy and tumor cell oxygenation. The Schiff base was constructed of HPCNPs with pyropheophorbide a-Cu (PPa-Cu). HPCNPs are concentrated in tumor sites under the guidance of CD44 proteins, and under the stimulation of tumor environment (weakly acidic), the Schiff base is destroyed to release free PPa...
February 19, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38371889/magnetic-resonance-imaging-in-patients-with-implanted-cardiac-electrotherapy-devices-a-statement-from-experts-of-the-polish-medical-society-of-radiology-the-polish-society-of-cardiology-and-the-polish-society-of-electroradiology
#33
REVIEW
Magdalena Marczak, Ewa Świerżyńska, Mateusz Śpiewak, Dawid Bodusz, Aneta Klotzka, Przemysław Mitkowski, Mateusz Tajstra, Tomasz Hryniewiecki, Zbigniew Serafin, Maciej Sterliński, Ilona Michałowska
The year 2023 marks 60 years since the first pacemaker was implanted in Poland. The number of implantable cardiac electrotherapy devices (CIEDs), including pacemakers, cardioverter-defibrillators, and resynchronization therapy systems, has been systematically increasing in the subsequent decades. It is estimated that nearly 500,000 Poles have an implanted cardiac electrotherapy device, making optimal diagnostic imaging with the use of magnetic resonance imaging (MRI) a clinically and epidemiologically important issue...
2024: Polish Journal of Radiology
https://read.qxmd.com/read/38366728/dampening-tumor-immune-escape-the-role-of-er-chaperones-in-immunogenic-chemotherapy
#34
JOURNAL ARTICLE
Selma Cifric, Marcello Turi, Pietro Folino, Cole Clericuzio, Francesca Barello, Tallya Maciel, Kenneth Carl Anderson, Annamaria Gulla
Preclinical and clinical research in the past two decades has redefined the mechanism of action of some chemotherapeutics that are able to activate the immune system against cancer when cell death is perceived by the immune cells. This immunogenic cell death (ICD) activates antigen-presenting cells (APCs) and T cells to induce immune-mediated tumor clearance. One of the key requirements to achieve this effect is the externalization of the danger-associated molecular patterns (DAMPs), molecules released or exposed by cancer cells during ICD that increase the visibility of the cancer cells by the immune system...
February 17, 2024: Antioxidants & Redox Signaling
https://read.qxmd.com/read/38361709/assessment-of-psychological-implications-and-quality-of-life-after-different-cardiac-device-implantation-in-saudi-arabia
#35
JOURNAL ARTICLE
Naeem Alshoaibi, Alaa Aljazar, Maal Bushnag, Afnan Aseeri, Layan Baeesa, Shahad Alruwaithi, Roba Bashawri, Amjad Marouf, Refan Alsaeed
BACKGROUND: Cardiac device therapy is likely to affect different aspects of patients' psychological well-being, such as their quality of life. The aim of this study was to examine the mental health status, specifically the conditions of depression and anxiety regarding implantable cardiac device patients. METHODS: A cross-sectional retrospective study was conducted in January 2022. This study was conducted at King Abdul-Aziz University Hospital in Jeddah, Saudi Arabia...
January 2024: Curēus
https://read.qxmd.com/read/38360252/relationship-between-sex-body-size-and-cardiac-resynchronization-therapy-benefit-a-patient-level-meta-analysis-of-randomized-controlled-trials
#36
JOURNAL ARTICLE
Daniel J Friedman, Antonio Olivas-Martinez, Frederik Dalgaard, Marat Fudim, William T Abraham, John G F Cleland, Anne B Curtis, Michael R Gold, Valentina Kutyifa, Cecilia Linde, Anthony S Tang, Fatima Ali-Ahmed, Lurdes Y T Inoue, Gillian D Sanders, Sana M Al-Khatib
BACKGROUND: Women might benefit more from cardiac resynchronization therapy(CRT) than men, and do so at shorter QRS durations(QRSd). OBJECTIVE: To determine if sex-based differences in CRT effects are better accounted for by height, body surface area (BSA), or left ventricular end-diastolic dimension(LVEDD). METHODS: We analyzed patient-level data from CRT trials (MIRACLE, MIRACLE-ICD, MIRACLE-ICD II, REVERSE, RAFT, COMPANION, and MADIT-CRT) using Bayesian Hierarchical Weibull regression models...
February 13, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://read.qxmd.com/read/38346611/back-to-the-basics-the-need-for-an-etiological-classification-of-chronic-heart-failure
#37
REVIEW
Filippos Triposkiadis, Andrew Xanthopoulos, Stavros G Drakos, Konstantinos Dean Boudoulas, Alexandros Briasoulis, John Skoularigis, Konstantinos Tsioufis, Harisios Boudoulas, Randall C Starling
The left ventricular (LV) ejection fraction (LVEF), despite its severe limitations, has had an epicentral role in heart failure (HF) classification, management, and risk stratification for decades. The major argument favoring the LVEF based HF classification has been that it defines groups of patients in which treatment is effective. However, this reasoning has recently collapsed, since medical treatment with neurohormonal inhibitors, has proved beneficial in most HF patients regardless of the LVEF. In addition, there has been compelling evidence, that the LVEF provides poor guidance for device treatment of chronic HF (implantation of cardioverter defibrillator, cardiac resynchronization therapy) since sudden cardiac death may occur and cardiac dyssynchronization may be disastrous in all HF patients...
February 10, 2024: Current Problems in Cardiology
https://read.qxmd.com/read/38333398/improved-outcomes-of-cardiac-resynchronization-therapy-with-a-defibrillator-in-systolic-heart-failure-analysis-of-the-japan-cardiac-device-treatment-registry-database
#38
JOURNAL ARTICLE
Hisashi Yokoshiki, Akihiko Shimizu, Takeshi Mitsuhashi, Kohei Ishibashi, Tomoyuki Kabutoya, Yasuhiro Yoshiga, Yusuke Kondo, Haruhiko Abe, Wataru Shimizu
BACKGROUND: Temporal change in outcomes of heart failure patients receiving cardiac resynchronization therapy with a defibrillator (CRT-D) is unknown. METHODS: We assess outcomes and underlying heart diseases of patients receiving CRT-D with analyzing database of the Japan cardiac device treatment registry (JCDTR) at the implantation year 2011-2015 and New JCDTR at the implantation year 2018-2021. RESULTS: Proportion of nonischemic heart diseases was about 70% in both the groups (JCDTR: 69%; New JCDTR: 72%)...
February 2024: Journal of Arrhythmia
https://read.qxmd.com/read/38323631/impact-of-a-pharmacist-managed-remote-heart-failure-program-in-patients-with-a-multisensor-capable-implanted-device
#39
JOURNAL ARTICLE
Audrey Kwon, Phuong Denomme
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: Added layers of remote management in heart failure (HF) have become available for patients with an implantable cardioverter defibrillator (ICD)...
February 7, 2024: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/38323311/the-combination-of-calreticulin-targeting-l-asnase-and-anti-pd-l1-antibody-modulates-the-tumor-immune-microenvironment-to-synergistically-enhance-the-antitumor-efficacy-of-radiotherapy
#40
JOURNAL ARTICLE
Ying Zhang, Venu Akhil, Ho Seong Seo, Hae Ran Park, Soo Hyun Kim, Sung-Hwan You, Zhipeng Liu, So-Young Kim, Rukhsora D Sultonova, Jung-Joon Min, Yeongjin Hong
Radiotherapy (RT) triggers immunogenic cell death (ICD). L-ASNase, which catalyzes the conversion of asparagine (Asn), thereby depleting it, is used in the treatment of blood cancers. In previous work, we showed that CRT3LP and CRT4LP, PASylated L-ASNases conjugated to the calreticulin (CRT)-specific monobodies CRT3 and CRT4, increase the efficacy of ICD-inducing chemotherapy. Here, we assessed their efficacy in tumor-bearing mice treated with RT. Methods: Monobody binding was evaluated by in silico molecular docking analysis...
2024: Theranostics
keyword
keyword
82281
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.